INVA Innoviva, Inc.
Healthcare$22.68+0.98%ClosedMarket Cap: $1.67B
As of 2026-05-26
Valuation
P/E (TTM)
5.64
PEG
0.01
P/B
1.24
P/S
3.91
EV/EBITDA
3.09
DCF Value
$62.92
FCF Yield
10.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
76.2%
Operating Margin
14.8%
Net Margin
118.9%
ROE
47.6%
ROA
27.5%
ROIC
2.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $98.0M | 77.4% | $38.2M | $186.6M | $— | — |
| Q4 null | $118.0M | 64.1% | $39.0M | $164.2M | $— | — |
| FY null | $425.1M | 72.3% | $163.7M | $271.2M | $— | — |
| Q3 null | $107.8M | 76.1% | $34.6M | $89.9M | $— | — |
| Q2 null | $100.3M | 89.4% | $-48.8M | $63.7M | $— | — |
| Q1 null | $88.6M | 90.0% | $-41.4M | $-46.6M | $— | — |
| Q4 null | $91.8M | 92.2% | $43.1M | $20.3M | $— | — |
| FY null | $358.7M | 89.8% | $166.9M | $23.4M | $— | — |
| Q3 null | $89.5M | 88.8% | $49.7M | $1.2M | $— | — |
| Q2 null | $103.4M | 82.2% | $54.7M | $-34.7M | $— | — |
| Q1 null | $77.5M | 85.8% | $25.8M | $36.5M | $— | — |
| Q4 2023 | $85.8M | 84.7% | $37.5M | $61.5M | $0.76 | — |